近年来，由于癌症治疗的进展和完善，癌症患者的预后和生存率有所改善；然而，这一人群的心血管后遗症有所增加，现已成为肿瘤患者死亡的第二大原因。最初，主要问题是心力衰竭和冠状动脉疾病，但现在越来越多的证据表明该人群心律失常风险增加，其中最常见的是心房颤动。对癌症心律失常并发症及其治疗的认识可能有助于肿瘤学家和心脏病学家开发有针对性的方法来治疗该人群的心律失常。在这篇综述中，我们提供了癌症患者心律失常的触发机制、患病率和治疗的最新概述。

Recently, prognosis and survival of cancer patients has improved due to progression and refinement of cancer therapies; however, cardiovascular sequelae in this population augmented and now represent the second cause of death in oncological patients. Initially, the main issue was represented by heart failure and coronary artery disease, but a growing body of evidence has now shed light on the increased arrhythmic risk of this population, atrial fibrillation being the most frequently encountered. Awareness of arrhythmic complications of cancer and its treatments may help oncologists and cardiologists to develop targeted approaches for the management of arrhythmias in this population. In this review, we provide an updated overview of the mechanisms triggering cardiac arrhythmias in cancer patients, their prevalence and management.